Evidence map›Paper›PMID 26207083›Full record

ArticleSynlett : accounts and rapid communications in synthetic organic chemistry

Brian Lowry, Christopher T Walsh, Chaitan Khosla

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Synlett : accounts and rapid communications in synthetic organic chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Cell-free biosynthesis of limonene using enzyme-enrichedSynthetic biology (Oxford, England) · 2019
    Article
  6. Cell-free synthetic biology forSynthetic and systems biotechnology · 2018
    Review
  7. Modules forSynthetic and systems biotechnology · 2017
    Review
  8. Natural product discovery from the human microbiome.The Journal of biological chemistry · 2017
    Review
  9. Article
  10. Mini-review:Computational and structural biotechnology journal · 2017
    Review
  11. Article
  12. Quo vadis, enzymology?Nature chemical biology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brian LowryDepartment of Chemical Engineering, Stanford University, 443 Via Ortega, Stanford, CA 94305, USA; blowry@stanford.edu.
Christopher T WalshStanford University Chemistry, Engineering, and Medicine for Human Health (ChEM-H), Stanford University, 443 Via Ortega, Stanford, CA 94305.
Chaitan KhoslaDepartment of Chemical Engineering, Stanford University, 443 Via Ortega, Stanford, CA 94305, USA; blowry@stanford.edu ; Stanford University Chemistry, Engineering, and Medicine for Human Health (ChEM-H), Stanford University, 443 Via Ortega, Stanford, CA 94305 ; Department of Chemistry, 333 Campus Drive Mudd Building, Stanford University, Stanford, CA 94305, USA; khosla@stanford.edu.

Funding

Structure, Mechanism, and Engineering of Assembly Line Polyketide SynthasesR01GM087934 · NIGMS · STANFORD UNIVERSITY · PI KHOSLA, CHAITAN · 2009 to 2021
$4.9M
NIGMS NIH HHS R01 GM087934
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntibioticsAntifungal AgentsAntiviral AgentsBiosynthesisEnzymesNatural Products

Identifiers

PMID26207083
PMCPMC4507746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.